Email This Article
Headlines & Perspectives
Dividend.com: Baxter Slips on Downgrade
By
Tom Reese and Paul Rubillo
06/08/09 - 01:37 PM EDT
Soleil analysts downgrade BAX following FTC pressure and claims of price collusion in the blood plasma industry.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,501.05 | 1,114.11 | 2,212.10 | 35.46 |
Oil *
71.84
|
|
UP
29.55
|
UP
7.70
|
UP
21.79
|
UP
0.06
|
10 Yr
3.55%
SPDR Gold
110.24
|
|
+0.28%
|
+0.70%
|
+0.99%
|
+0.17%
|
Data delayed 20 minutes |


Connect with TheStreet